Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy Life Science Investing
Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026 Life Science Investing
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium Life Science Investing
Acadia Pharmaceuticals Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave - NV-387 is Effective Against H3N2 Life Science Investing
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer Life Science Investing
BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS Patient Biotech Investing
Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer's Disease Life Science Investing
Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis Biotech Investing
Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines Life Science Investing
Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs Life Science Investing
